返回
TYK Medicines, Inc（02410.HK）價格
02410.HK 股價走勢圖
TYK MEDICINES-B (02410.HK)
TYK Medicines, Inc
HK$12.76
-0.39%
$-0.05
休市： Feb 16, 12:00:00 HKT
關鍵數據
前收市價
$12.8
開盤價
$12.81
當日範圍
$12.71 - $12.98
52週區間
$12.1 - $46.1
交易量
78.0K
平均成交量
2.9M
每股盈餘 (TTM)
-0.85
股息收益率
--
市值
$4.7B
什麼是 TYK MEDICINES-B？
TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai and currently employs 163 full-time employees. The company went IPO on 2024-08-20. The firm is primarily focused on small molecule drug development, and its main products include TY-9591, TY-302 and TY-2136. TY-9591 is a third-generation EGFR-TKI with antitumor effects on EGFR mutations. TY-302 is a potent, selective oral CDK4/6 inhibitor developed for the treatment of advanced solid tumors, including breast cancer and prostate cancer. TY-2136b is an internally developed, oral ROS1/NTRK inhibitor for the treatment of solid tumors.